Ken Griffin’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8K | Sell |
16,227
-9,945
| -38% | -$9.05K | ﹤0.01% | 5660 |
|
|
2025
Q1 | $25.9K | Buy |
+26,172
| New | +$25.9K | ﹤0.01% | 5538 |
|
|
2024
Q4 | – | Sell |
-27,717
| Closed | -$34.1K | – | 6020 |
|
|
2024
Q3 | $34.1K | Buy |
27,717
+11,680
| +73% | +$14.4K | ﹤0.01% | 5217 |
|
|
2024
Q2 | $22.5K | Buy |
+16,037
| New | +$22.5K | ﹤0.01% | 5375 |
|
|
2023
Q3 | – | Sell |
-14,877
| Closed | -$30.6K | – | 5898 |
|
|
2023
Q2 | $30.6K | Buy |
+14,877
| New | +$30.6K | ﹤0.01% | 5140 |
|
|
2023
Q1 | – | Sell |
-17,383
| Closed | -$41.5K | – | 5940 |
|
|
2022
Q4 | $41.5K | Buy |
+17,383
| New | +$41.5K | ﹤0.01% | 5337 |
|